Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.21
Relación precio/flujo de caja
0.24
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4382 | ALGS Aligos Therapeutics, Inc. - Common stock | 5.86 USD | -15.20% | -15.44% | +36.60% | -40.14% | 36.55 M USD | ||
| 4384 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.52 USD | -8.43% | +22.58% | +33.33% | -62.75% | 36.50 M USD | ||
| 4392 | CNTX Context Therapeutics Inc. - Common Stock | 0.39 USD | +2.63% | -17.02% | -37.10% | -54.12% | 35.83 M USD | ||
| 4396 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.10 USD | -3.67% | -23.36% | -53.54% | -77.91% | 35.55 M USD |